A key pillar of the refined British American Tobacco plc (LON:BATS) strategy announced earlier this year is the delivery of a Sustainable Future
Photo: HANS WIEDL Captions are provided by our contributors
LONGHORN SAYS: "Longhorn is dedicated to bringing you moist snuff
This is not the recommended way to test fuses if they are plugged in
C86.4 has a new inclusion term: Blastic plasmacytoid dedritic cell neoplasm (BPDCN). C96.2 is revised to Malignant mast cell neoplasm , and is no longer applicable to Aggressive systemic mastocytosis or Mast cell sarcoma. An Excludes1 note under C96.2 is revised to indolent mastocytosis (D47.02). New codes in this subcategory include: C96.20 Malignant mast cell neoplasm, unspecified C96.21 Aggressive systemic mastocytosis C96.22 Mast cell sarcoma C96.29 Other malignant mast cell neoplasm Code D47.0 is revised to Mast cell neoplasms of uncertain behavior , removing the reference to histiocytic tumors, and deleting the inclusion of indolent systemic mastocytosis, mast cell tumor not otherwise specified (NOS), and mastocytoma NOS
As strategy, from an outsider's standpoint, it was not
